Thierry Facon, Sonja Zweegman, Vania Hungria, Nizar J. Bahlis, Christopher P. Venner, Marc Justin Braunstein, Ludek Pour, Josep Marti, Supratik Basu, Yael C. Cohen, Morio Matsumoto, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Meral Beksac, Angelo Maiolino, Jianping Wang, Melissa Rowe, Robin L. Carson, Saad Z. Usmani. "Daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) in patients with newly diagnosed multiple myeloma (NDMM): Subgroup analysis of transplant-ineligible (TIE) patients in the phase 3 CEPHEUS study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7516